title: Rivaroxaban and pulmonary embolism: no better than established anticoagulant therapy.
abstract: No tangible advantage over heparin therapy followed by a vitamin K antagonist, in an unblinded trial.
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban